Apoquel in dogs: indications and monitoring

Apoquel is a prescription medicine. The treatment decision, treatment phases and monitoring are the veterinarian’s responsibility.

Defined indications

Oclacitinib must not be described as a simple antihistamine or as an undifferentiated solution for every allergy. The authorised indication and limitations of use are those in the current summary of product characteristics.

Itching may have parasitic, infectious or allergic causes that require diagnosis.

Before and during treatment

The veterinarian assesses age, clinical status, infections and other treatments. Any phases of the plan and monitoring are not converted into standalone instructions.

Do not stop, restart or combine the medicine without instructions.

Adverse effects

New symptoms, infections, gastrointestinal problems or persistent changes should be reported to the veterinarian. The page does not use claims of absolute safety.

Sources and document updates

This information is general and does not replace diagnosis, prescription or instructions from a veterinarian. For a medicine, the summary of product characteristics or package leaflet for the specific presentation is authoritative.

• European Medicines Agency — Apoquel - EPAR (accessed 24/07/2026)
• Union Product Database — Veterinary medicines authorised in the European Union (accessed 24/07/2026)

Editorial transparency: sources are provided to allow the documents to be checked. Professional review is only declared after genuine approval by a qualified, identifiable person.